👶 What are the benefits & risks of using #Doxapram (a stimulating medicine) for breath‐holding episodes #apnea in premature babies? 🔎 📚 Evidence from 8 RCTs with 248 infants were included in this #SystematicReview https://t.co/Zr08T37fBM
Great summary of current evidence on Doxapram. We are pushing the recruitement of the NL-BE- Canada Doxa trial forward with great effort of many teams in 18 sites… 5 more currently steadying up to have final answers on long term effect and safety.
RT @CochraneNeonate: This review on Doxapram (D) in preterm infants included 8 RCTs: - 5 for treatment of apnea: D may slightly reduce fail…
RT @Saludteca: Doxapram para la prevención y el tratamiento de la apnea en recién nacidos prematuros https://t.co/2lQLn7wcmU 🆕✅Esta revisi…
Doxapram para la prevención y el tratamiento de la apnea en recién nacidos prematuros https://t.co/2lQLn7wcmU 🆕✅Esta revisión sobre Doxapram (D) en recién nacidos prematuros incluyó 8 ECAs, 5 para el tratamiento y 3 para prevenir la reintubación @Cochrane
RT @CochraneNeonate: This review on Doxapram (D) in preterm infants included 8 RCTs: - 5 for treatment of apnea: D may slightly reduce fail…
RT @CochraneNeonate: This review on Doxapram (D) in preterm infants included 8 RCTs: - 5 for treatment of apnea: D may slightly reduce fail…
RT @CochraneNeonate: This review on Doxapram (D) in preterm infants included 8 RCTs: - 5 for treatment of apnea: D may slightly reduce fail…
RT @CochraneNeonate: This review on Doxapram (D) in preterm infants included 8 RCTs: - 5 for treatment of apnea: D may slightly reduce fail…
RT @CochraneNeonate: This review on Doxapram (D) in preterm infants included 8 RCTs: - 5 for treatment of apnea: D may slightly reduce fail…
RT @CochraneNeonate: This review on Doxapram (D) in preterm infants included 8 RCTs: - 5 for treatment of apnea: D may slightly reduce fail…
RT @CochraneNeonate: This review on Doxapram (D) in preterm infants included 8 RCTs: - 5 for treatment of apnea: D may slightly reduce fail…
RT @CochraneNeonate: This review on Doxapram (D) in preterm infants included 8 RCTs: - 5 for treatment of apnea: D may slightly reduce fail…
RT @CochraneNeonate: This review on Doxapram (D) in preterm infants included 8 RCTs: - 5 for treatment of apnea: D may slightly reduce fail…
This review on Doxapram (D) in preterm infants included 8 RCTs: - 5 for treatment of apnea: D may slightly reduce failure in apnea reduction - 3 to prevent reintubation: D may reduce apnea when administered with caffeine. Two multicenter RCTs are ongoing.